These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 38697834

  • 21. Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.
    Ravera M, Gabano E, Zanellato I, Perin E, Arrais A, Osella D.
    Dalton Trans; 2016 Nov 01; 45(43):17233-17240. PubMed ID: 27722707
    [Abstract] [Full Text] [Related]

  • 22. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
    Navas F, Chocarro-Calvo A, Iglesias-Hernández P, Fernández-García P, Morales V, García-Martínez JM, Sanz R, De la Vieja A, García-Jiménez C, García-Muñoz RA.
    J Med Chem; 2024 Apr 25; 67(8):6410-6424. PubMed ID: 38592014
    [Abstract] [Full Text] [Related]

  • 23. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
    Markova L, Maji M, Kostrhunova H, Novohradsky V, Kasparkova J, Gibson D, Brabec V.
    J Med Chem; 2024 Jun 13; 67(11):9745-9758. PubMed ID: 38819023
    [Abstract] [Full Text] [Related]

  • 24. ctc-[Pt(NH3)2(cinnamate)(valproate)Cl2] is a highly potent and low-toxic triple action anticancer prodrug.
    Li Y, Shi S, Zhang S, Gan Z, Wang X, Zhao X, Zhu Y, Cao M, Wang X, Li W.
    Dalton Trans; 2021 Aug 28; 50(32):11180-11188. PubMed ID: 34338267
    [Abstract] [Full Text] [Related]

  • 25. Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs.
    Spector D, Pavlov K, Beloglazkina E, Krasnovskaya O.
    Int J Mol Sci; 2022 Nov 22; 23(23):. PubMed ID: 36498837
    [Abstract] [Full Text] [Related]

  • 26. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY, Wang DB, Song XQ, Wu YG, Chen Q, Zhao CL, Li JY, Cheng SH, Xu JY.
    Eur J Med Chem; 2018 Sep 05; 157():1292-1299. PubMed ID: 30195239
    [Abstract] [Full Text] [Related]

  • 27. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG, Pan ZY, Zhang DY, Cao Q, Ji LN, Mao ZW.
    ACS Appl Mater Interfaces; 2020 Sep 30; 12(39):43444-43455. PubMed ID: 32883070
    [Abstract] [Full Text] [Related]

  • 28. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q, Yang Y, Lin X, Ma W, Chen G, Li W, Wang X, Yu Z.
    Chem Commun (Camb); 2018 May 22; 54(42):5369-5372. PubMed ID: 29744485
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
    Song Y, Suntharalingam K, Yeung JS, Royzen M, Lippard SJ.
    Bioconjug Chem; 2013 Oct 16; 24(10):1733-40. PubMed ID: 23957697
    [Abstract] [Full Text] [Related]

  • 30. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D.
    J Inorg Biochem; 2015 Sep 16; 150():1-8. PubMed ID: 26042542
    [Abstract] [Full Text] [Related]

  • 31. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F, Sun T, Xu Z, Wang Z, Kong W, To MW, Wang F, Zhu G.
    Dalton Trans; 2016 Aug 16; 45(33):13052-60. PubMed ID: 27430044
    [Abstract] [Full Text] [Related]

  • 32. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.
    Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896
    [Abstract] [Full Text] [Related]

  • 33. Two-step activation prodrugs: transplatin mediated binding of chemotherapeutic agents to vitamin B12.
    Tran MT, Furger E, Alberto R.
    Org Biomol Chem; 2013 May 21; 11(19):3247-54. PubMed ID: 23584074
    [Abstract] [Full Text] [Related]

  • 34. Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex.
    Venkatesh V, Wedge CJ, Romero-Canelón I, Habtemariam A, Sadler PJ.
    Dalton Trans; 2016 Aug 16; 45(33):13034-7. PubMed ID: 27189101
    [Abstract] [Full Text] [Related]

  • 35. Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men.
    Gibson D.
    ChemMedChem; 2021 Jul 20; 16(14):2188-2191. PubMed ID: 33928760
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y, Wang Y, Liu X, Zhou J, Wang X, Feng H, Liu H.
    Drug Des Devel Ther; 2020 Jul 20; 14():5205-5215. PubMed ID: 33268983
    [Abstract] [Full Text] [Related]

  • 38. Design and investigation of photoactivatable platinum(iv) prodrug complexes of cisplatin.
    Lee VEY, Chin CF, Ang WH.
    Dalton Trans; 2019 Jun 07; 48(21):7388-7393. PubMed ID: 30957798
    [Abstract] [Full Text] [Related]

  • 39. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.
    Marsh JW, Hacker L, Huang S, Boulet MHC, White JRG, Martin LAW, Yeomans MA, Han HH, Diez-Perez I, Musgrave RA, Hammond EM, Sedgwick AC.
    Dalton Trans; 2024 Sep 10; 53(35):14811-14816. PubMed ID: 39169877
    [Abstract] [Full Text] [Related]

  • 40. Oxoplatin-B, a cisplatin-based platinum(IV) complex with photoactive BODIPY for mitochondria specific "chemo-PDT" activity.
    Bera A, Gautam S, Raza MK, Kondaiah P, Chakravarty AR.
    J Inorg Biochem; 2021 Oct 10; 223():111526. PubMed ID: 34246120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.